+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Translate
+ Recently Requested

Are high-risk hypertensive patients being prescribed concomitant statin therapy?: a retrospective cohort study



Are high-risk hypertensive patients being prescribed concomitant statin therapy?: a retrospective cohort study



American Journal of Cardiovascular Drugs 9(5): 299-308



Treatment guidelines for dyslipidemic patients have focused on lipid levels and risk assessments. However, normolipidemic patients who have multiple risk factors for cardiovascular disease may also benefit from HMG-CoA reductase inhibitor (statin) therapy. We examined the frequency of statin prescriptions in patients initiating antihypertensive drug treatment in a US managed-care setting. STUDY DESIGN AND PATIENT: This retrospective cohort study used the PharMetrics' Patient-Centric Database to identify enrollees initiating antihypertensive treatment (September 2001 to February 2004). Patients newly treated with antihypertensives and with various levels of coronary heart disease (CHD) risk (including dyslipidemia, established CHD, type 2 diabetes mellitus, and no CHD but three or more cardiovascular risk factors) were included in the study. Cumulative probability of receiving statin therapy each month after antihypertensive initiation. Multivariable logistic regression was used to identify factors associated with receiving concomitant statin therapy. Of 142 389 patients (mean age 51.7 years) newly treated with antihypertensives, 32 056 (22.5%) were prescribed statins within 1 year. The cumulative probability of being prescribed a statin increased with increasing numbers of CHD risk factors, irrespective of dyslipidemia status. After adjusting for age, sex, and other potential predictors, patients were more likely to receive statin therapy if they had a history of dyslipidemia (adjusted odds ratio [AOR] 5.68 [95% CI 5.52, 5.85]), established CHD/congestive heart failure (AOR 3.39 [95% CI 3.16, 3.63]), or three or more additional cardiovascular risk factors but no CHD (AOR 3.01 [95% CI 2.74, 3.30]). Among patients beginning antihypertensive treatment, those with established CHD or CHD risk factors were more likely to receive statins, but a substantial fraction did not fill any statin prescription. The increased use of statin therapy could benefit many hypertensive patients with additional CHD risk factors.

(PDF emailed within 0-6 h: $19.90)

Accession: 051627598

Download citation: RISBibTeXText

PMID: 19791839

DOI: 10.2165/11312110-000000000-00000


Related references

Comparison of the Risk of Gastrointestinal Bleeding among Different Statin Exposures with Concomitant Administration of Warfarin: Electronic Health Record-Based Retrospective Cohort Study. Plos One 11(7): E0158130, 2017

Risk factors for amendment in type, duration and setting of prescribed outpatient parenteral antimicrobial therapy (OPAT) for adult patients with cellulitis: a retrospective cohort study and CART analysis. Postgraduate Medical Journal 94(1107): 25-31, 2017

Association between Statin Use and Sepsis Risk in Patients with Dementia: A Retrospective Cohort Study. International Journal of Environmental Research and Public Health 16(9), 2019

Risk factors for the development of hypermagnesemia in patients prescribed magnesium oxide: a retrospective cohort study. Journal of Pharmaceutical Health Care and Sciences 5: 4, 2019

A Retrospective Study Of Mortality In Risk Patients With High Dose Statin Usage And No Statin Usage. Value in Health 17(7): A478, 2014

Should highly active antiretroviral therapy be prescribed in critically ill HIV-infected patients during the ICU stay? A retrospective cohort study. Aids Research and Therapy 9(1): 27, 2012

Does use of pooled cohort risk score overestimate the use of statin?: a retrospective cohort study in a primary care setting. Bmc Family Practice 15: 172, 2015

Risk of Hospitalization for Cardiovascular Events with β-Blockers in Hypertensive Patients: A Retrospective Cohort Study. Cardiology and Therapy 7(2): 173-183, 2018

Risk of cardiovascular disease and all cause mortality among patients with type 2 diabetes prescribed oral antidiabetes drugs: retrospective cohort study using UK general practice research database. Yearbook of Cardiology 2010: 273-275, 2010

Risk of cardiovascular disease and all cause mortality among patients with type 2 diabetes prescribed oral antidiabetes drugs: retrospective cohort study using UK general practice research database. Bmj 339: B4731, 2009

Characterization of diabetes risk factors in patients prescribed chronic statin therapy. Therapeutic Advances in Chronic Disease 5(5): 206-211, 2014

A retrospective cohort study evaluating efficacy in high-risk patients with chronic lower extremity ulcers treated with negative pressure wound therapy. International Wound Journal 11(5): 483-488, 2015

Relationship between initial therapy and blood pressure control for high-risk hypertension patients in the UK: a retrospective cohort study from the THIN general practice database. Bmj Open 7(7): E015527, 2018

Association of Statin Use with Increased Risk of Musculoskeletal Conditions: A Retrospective Cohort Study. Drug Safety 41(10): 939-950, 2018

Hyperlipidemia, statin use and the risk of developing depression: a nationwide retrospective cohort study. General Hospital Psychiatry 36(5): 497-501, 2015